(Q35635570)

9 August 2017

1 reference

title

Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia (English)

1 reference

9 August 2017

1 reference

3

Ofer Shpilberg

1 reference

9 August 2017

Tamar Hayon

1

1 reference

9 August 2017

Alexander Dvilansky

series ordinal

2

1 reference

9 August 2017

Ilana Nathan

series ordinal

4

1 reference

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

44

1 reference

9 August 2017

issue

11

1 reference

9 August 2017

page(s)

1957-1962

1 reference

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

An improved colorimetric assay for interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Towards an optimized MTT assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

21 January 2018

An improved MTT assay.

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

An improved MTT assay using the electron-coupling agent menadione

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Comparative analysis of using MTT and XTT in colorimetric assays for quantitating bovine neutrophil bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1/CIP1) proteins in human acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

The DiSC assay. A cost-effective guide to treatment for chronic lymphocytic leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116607

10.1080/1042819031000116607

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference